Jason Ryan - Net Worth and Insider Trading
Jason Ryan Net Worth
The estimated net worth of Jason Ryan is at least $16 Million dollars as of 2024-11-05. Jason Ryan is the Executive Chairman of GeneDx Holdings Corp and owns about 120,576 shares of GeneDx Holdings Corp (WGS) stock worth over $9 Million. Jason Ryan is also the CFO of Foundation Medicine Inc and owns about 49,170 shares of Foundation Medicine Inc (FMI) stock worth over $7 Million. Details can be seen in Jason Ryan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jason Ryan has not made any transactions after 2023-11-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jason Ryan
Jason Ryan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jason Ryan owns 5 companies in total, including Magenta Therapeutics Inc (MGTA) , Foundation Medicine Inc (FMI) , and GeneDx Holdings Corp (WGS) among others .
Click here to see the complete history of Jason Ryan’s form 4 insider trades.
Insider Ownership Summary of Jason Ryan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MGTA | Magenta Therapeutics Inc | 2019-01-01 | See Remarks |
| FMI | Foundation Medicine Inc | 2018-07-31 | Chief Financial Officer |
| WGS | GeneDx Holdings Corp | 2023-11-17 | director |
 | | 2021-05-26 | director |
| | 2023-06-08 | director |
Jason Ryan Latest Holdings Summary
Jason Ryan currently owns a total of 2 stocks. Among these stocks, Jason Ryan owns 120,576 shares of GeneDx Holdings Corp (WGS) as of November 17, 2023, with a value of $9 Million and a weighting of 57.54%. Jason Ryan also owns 49,170 shares of Foundation Medicine Inc (FMI) as of July 2, 2018, with a value of $7 Million and a weighting of 42.46%.
Latest Holdings of Jason Ryan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| WGS | GeneDx Holdings Corp | 2023-11-17 | 120,576 | 75.70 | 9,127,603 |
| FMI | Foundation Medicine Inc | 2018-07-02 | 49,170 | 137.00 | 6,736,290 |
Holding Weightings of Jason Ryan
Jason Ryan Form 4 Trading Tracker
According to the SEC Form 4 filings, Jason Ryan has made a total of 4 transactions in GeneDx Holdings Corp (WGS) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in GeneDx Holdings Corp is the acquisition of 114,742 shares on November 17, 2023, which cost Jason Ryan around $161,786.
According to the SEC Form 4 filings, Jason Ryan has made a total of 0 transactions in Foundation Medicine Inc (FMI) over the past 5 years. The most-recent trade in Foundation Medicine Inc is the sale of 3,403 shares on July 2, 2018, which brought Jason Ryan around $465,054.
Insider Trading History of Jason Ryan
- 1
Jason Ryan Trading Performance
GuruFocus tracks the stock performance after each of Jason Ryan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jason Ryan is 215.63%. GuruFocus also compares Jason Ryan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jason Ryan within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jason Ryan's insider trading performs compared to the benchmark.
Performance of Jason Ryan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 51.88 | | | | | |
| Relative Return to S&P 500(%) | 47.33 | | | | | |
Jason Ryan Ownership Network
Ownership Network List of Jason Ryan
Ownership Network Relation of Jason Ryan
Jason Ryan Owned Company Details
What does Magenta Therapeutics Inc do?
Who are the key executives at Magenta Therapeutics Inc?
Jason Ryan is the See Remarks of Magenta Therapeutics Inc. Other key executives at Magenta Therapeutics Inc include director & 10 percent owner Peter Evan Harwin , director & 10 percent owner Tomas Kiselak , and director & 10 percent owner Fairmount Funds Management Llc .
Magenta Therapeutics Inc (MGTA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Magenta Therapeutics Inc (MGTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Magenta Therapeutics Inc (MGTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Magenta Therapeutics Inc (MGTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Magenta Therapeutics Inc Insider Transactions
Jason Ryan Mailing Address
Above is the net worth, insider trading, and ownership report for Jason Ryan. You might contact Jason Ryan via mailing address: C/o Foundation Medicine, Inc., One Kendall Square, Suite B3501, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
